ArticleFrontiers in neurology2021

Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)-Data From a Local Norwegian Cohort.

Andreas K Jaklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.